- Home
- PMVP vs FCO Comparison
PMVP vs FCO Comparison
Compare PMVP & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMVP | FCO |
|---|---|---|
| Founded | 2013 | 1991 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.0M | 39.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PMVP | FCO |
|---|---|---|
| Price | $1.23 | $2.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 268.4K | 100.1K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.81 | $4.73 |
| 52 Week High | $1.84 | $6.63 |
Technical Indicators
Market Signals| Indicator | PMVP | FCO |
|---|---|---|
| Relative Strength Index (RSI) | 46.37 | 57.30 |
| Support Level | $1.20 | $2.80 |
| Resistance Level | $1.27 | $2.91 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 63.84 | 100.00 |
Price Performance
Historical ComparisonAbout PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.